Naloxone Hydrochloride · NALOXONE HYDROCHLORIDE 4 mg/.1mL · Spray · Nasal · Amneal Pharmaceuticals LLC
NDC 69238-2104-07 · 2 VIAL, SINGLE-DOSE in 1 CARTON / .1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
16 companies supply this market — deep enough that no single failure threatens the supply. The price has fallen 34% in a year, to $16.92 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Some pressure is visible, but not much — here’s everything the score found to count.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals LLC | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Aug 27, 2026 | Sep 3, 2026 |
| Advanced Rx of Tennessee, LLC | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| Amerisource Bergen | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| CVS Pharmacy, Inc | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| Harm Reduction Therapeutics, Inc. | NALOXONE HYDROCHLORIDE 3 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| International Medication Systems, Ltd. | NALOXONE HYDROCHLORIDE 4 mg/.25mL | Jul 15, 2026 | Sep 2, 2026 |
| Padagis Israel Pharmaceuticals Ltd | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| Strategic Sourcing Services LLC | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| Walgreen Co. | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Aug 28, 2026 |
| Amneal Pharmaceuticals NY LLC | NALOXONE HYDROCHLORIDE 4 mg/.1mL | Jul 15, 2026 | Aug 26, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Naloxone Hydrochloride — NDC 69238-2104-07," retrieved September 3, 2026, https://drugdashboards.com/drug/69238210407.
Free to cite with attribution — see how the data is put together.